Literature DB >> 18678847

Against diagnosis.

Andrew J Vickers1, Ethan Basch, Michael W Kattan.   

Abstract

The act of diagnosis requires that patients be placed in a binary category of either having or not having a certain disease. Accordingly, the diseases of particular concern for industrialized countries--such as type 2 diabetes, obesity, or depression--require that a somewhat arbitrary cut-point be chosen on a continuous scale of measurement (for example, a fasting glucose level >6.9 mmol/L [>125 mg/dL] for type 2 diabetes). These cut-points do not adequately reflect disease biology, may inappropriately treat patients on either side of the cut-point as 2 homogenous risk groups, fail to incorporate other risk factors, and are invariable to patient preference. This article discusses risk prediction as an alternative to diagnosis: Patient risk factors (blood pressure, age) are combined into a single statistical model (risk for a cardiovascular event within 10 years) and the results are used in shared decision making about possible treatments. The authors compare and contrast the diagnostic and risk prediction approaches and attempt to identify the types of medical problem to which each is best suited.

Entities:  

Mesh:

Year:  2008        PMID: 18678847      PMCID: PMC2677291          DOI: 10.7326/0003-4819-149-3-200808050-00010

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  9 in total

1.  Causes of inconsistency in diagnosing and classifying intraductal proliferations of the breast. European Commission Working Group on Breast Screening Pathology.

Authors:  C W Elston; J P Sloane; I Amendoeira; N Apostolikas; J P Bellocq; S Bianchi; W Boecker; G Bussolati; D Coleman; C E Connolly; P Dervan; M Drijkoningen; V Eusebi; D Faverly; R Holland; J Jacquemier; M Lacerda; J Martinez-Penuela; C de Miguel; S Mossi; C Munt; J L Peterse; F Rank; A Reiner; M Sylvan; C A Wells; B Zafrani
Journal:  Eur J Cancer       Date:  2000-09       Impact factor: 9.162

2.  Clinical problem solving. A hand-carried diagnosis.

Authors:  Clinton L Greenstone; Sanjay Saint; Richard H Moseley
Journal:  N Engl J Med       Date:  2007-06-07       Impact factor: 91.245

3.  Effectiveness and efficiency of different guidelines on statin treatment for preventing deaths from coronary heart disease: modelling study.

Authors:  Douglas G Manuel; Kelvin Kwong; Peter Tanuseputro; Jenny Lim; Cameron A Mustard; Geoffrey M Anderson; Sten Ardal; David A Alter; Andreas Laupacis
Journal:  BMJ       Date:  2006-05-31

4.  Cancer statistics, 2007.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Taylor Murray; Jiaquan Xu; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2007 Jan-Feb       Impact factor: 508.702

5.  Are some patients likely to benefit from recombinant tissue-type plasminogen activator for acute ischemic stroke even beyond 3 hours from symptom onset?

Authors:  David M Kent; Robin Ruthazer; Harry P Selker
Journal:  Stroke       Date:  2003-02       Impact factor: 7.914

6.  An independently derived and validated predictive model for selecting patients with myocardial infarction who are likely to benefit from tissue plasminogen activator compared with streptokinase.

Authors:  David M Kent; Rodney A Hayward; John L Griffith; Sandeep Vijan; Joni R Beshansky; Robert M Califf; Harry P Selker
Journal:  Am J Med       Date:  2002-08-01       Impact factor: 4.965

7.  Needle biopsies on autopsy prostates: sensitivity of cancer detection based on true prevalence.

Authors:  Gabriel P Haas; Nicolas Barry Delongchamps; Richard F Jones; Vishal Chandan; Angel M Serio; Andrew J Vickers; Mary Jumbelic; Gregory Threatte; Rus Korets; Hans Lilja; Gustavo de la Roza
Journal:  J Natl Cancer Inst       Date:  2007-09-25       Impact factor: 13.506

Review 8.  Systematic review of statistical methods used in molecular marker studies in cancer.

Authors:  Andrew J Vickers; Kwang Jang; Daniel Sargent; Hans Lilja; Michael W Kattan
Journal:  Cancer       Date:  2008-04-15       Impact factor: 6.860

Review 9.  Systematic review: gene expression profiling assays in early-stage breast cancer.

Authors:  Luigi Marchionni; Renee F Wilson; Antonio C Wolff; Spyridon Marinopoulos; Giovanni Parmigiani; Eric B Bass; Steven N Goodman
Journal:  Ann Intern Med       Date:  2008-02-04       Impact factor: 25.391

  9 in total
  21 in total

1.  Prostate cancer: Personalized risk - stratified screening or abandoning it altogether?

Authors:  Sigrid V Carlsson; Michael W Kattan
Journal:  Nat Rev Clin Oncol       Date:  2016-02-02       Impact factor: 66.675

2.  A theory of health science and the healing arts based on the philosophy of Bernard Lonergan.

Authors:  Patrick R Daly
Journal:  Theor Med Bioeth       Date:  2009-03-13

3.  Association Between 6-Week Postdischarge Risk Classification and 12-Month Outcomes After Orthopedic Trauma.

Authors:  Renan C Castillo; Yanjie Huang; Daniel Scharfstein; Katherine Frey; Michael J Bosse; Andrew N Pollak; Heather A Vallier; Kristin R Archer; Robert A Hymes; Anna B Newcomb; Ellen J MacKenzie; Stephen Wegener; Joseph R Hsu; Madhav A Karunakar; Rachel B Seymour; Stephen H Sims; Eileen Flores; Christine Churchill; David J Hak; Corey E Henderson; Hassan R Mir; Daniel S Chan; Anjan R Shah; Barbara Steverson; Jerald Westberg; Joshua L Gary; Timothy S Achor; Andrew Choo; John W Munz; Melissa Porrey; Sarah Hendrickson; Mary A Breslin; Todd O McKinley; Greg E Gaski; Laurence B Kempton; Anthony T Sorkin; Walter W Virkus; Lauren C Hill; Clifford B Jones; Debra L Sietsema; Robert V O'Toole; Katherine Ordonio; Andrea L Howe; Timothy J Zerhusen; William Obremskey; Robert H Boyce; A Alex Jahangir; Cesar S Molina; Manish K Sethi; Susan W Vanston; Eben A Carroll; Danielle Yemiola Drye; Martha B Holden; Susan C Collins; Elizabeth Wysocki
Journal:  JAMA Surg       Date:  2019-02-20       Impact factor: 14.766

4.  Addressing the ethical, policy, and social challenges of preclinical Alzheimer disease.

Authors:  Jason Karlawish
Journal:  Neurology       Date:  2011-09-14       Impact factor: 9.910

5.  An integral approach to health science and healthcare.

Authors:  Patrick Daly
Journal:  Theor Med Bioeth       Date:  2017-02

6.  The Care of Patients With Complex Mood Disorders.

Authors:  Zachary A Cordner; Dean F MacKinnon; J Raymond DePaulo
Journal:  Focus (Am Psychiatr Publ)       Date:  2020-04-23

7.  Development and validation of a patient self-assessment score for diabetes risk.

Authors:  Heejung Bang; Alison M Edwards; Andrew S Bomback; Christie M Ballantyne; David Brillon; Mark A Callahan; Steven M Teutsch; Alvin I Mushlin; Lisa M Kern
Journal:  Ann Intern Med       Date:  2009-12-01       Impact factor: 25.391

8.  Screening strategies to identify sepsis in the prehospital setting: a validation study.

Authors:  Daniel J Lane; Hannah Wunsch; Refik Saskin; Sheldon Cheskes; Steve Lin; Laurie J Morrison; Damon C Scales
Journal:  CMAJ       Date:  2020-03-09       Impact factor: 8.262

9.  Subgroups of Long-Term Sick-Listed Based on Prognostic Return to Work Factors Across Diagnoses: A Cross-Sectional Latent Class Analysis.

Authors:  Martin Inge Standal; Lene Aasdahl; Chris Jensen; Vegard Stolsmo Foldal; Roger Hagen; Egil Andreas Fors; Marit Solbjør; Odin Hjemdal; Margreth Grotle; Ingebrigt Meisingset
Journal:  J Occup Rehabil       Date:  2020-10-14

10.  Prognosis research strategy (PROGRESS) 1: a framework for researching clinical outcomes.

Authors:  Harry Hemingway; Peter Croft; Pablo Perel; Jill A Hayden; Keith Abrams; Adam Timmis; Andrew Briggs; Ruzan Udumyan; Karel G M Moons; Ewout W Steyerberg; Ian Roberts; Sara Schroter; Douglas G Altman; Richard D Riley
Journal:  BMJ       Date:  2013-02-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.